RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.42B
AUM Growth
-$48.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
97
New
Increased
Reduced
Closed

Top Buys

1
+$31.5M
2
+$21.5M
3
+$17M
4
MCK icon
McKesson
MCK
+$14M
5
ELV icon
Elevance Health
ELV
+$9.32M

Top Sells

1
+$33.7M
2
+$20.4M
3
+$14M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.23M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.09M

Sector Composition

1 Healthcare 96.82%
2 Industrials 1.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$4.8M 0.34%
600,000
+340,000
77
$4.65M 0.33%
250,000
78
$4.48M 0.31%
80,000
79
$4.47M 0.31%
105,000
+10,000
80
$4.36M 0.31%
325,000
81
$4.3M 0.3%
800,000
+115,598
82
$3.57M 0.25%
60,000
83
$3.4M 0.24%
+140,000
84
$3.34M 0.23%
90,000
85
$2.52M 0.18%
75,000
86
$2.04M 0.14%
8,000
87
$2.04M 0.14%
60,000
88
$1.55M 0.11%
3,750
89
$1.5M 0.11%
150,000
+50,000
90
$1.36M 0.1%
265,000
91
$992K 0.07%
150,000
92
$756K 0.05%
4,392
-195,608
93
– –
-35,000
94
– –
-600,000
95
– –
-110,000
96
– –
-10,000
97
– –
-25,000
1 2 3
4